Phosphoserine Aminotransferase Pathogenetic Variants in Serine Deficiency Disorders: A Functional Characterization
Biomolecules · 2023
DOI: 10.3390/biom13081219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Francesco Marchesani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, 43124 Parma, Italy. Hauptthemen laut MEDLINE: Transaminases, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN-2017—Dissecting Serine Metabolism in the Brain.
Abstract (Originalsprache)
In humans, the phosphorylated pathway (PP) converts the glycolytic intermediate D-3-phosphoglycerate (3-PG) into L-serine through the enzymes 3-phosphoglycerate dehydrogenase, phosphoserine aminotransferase (PSAT) and phosphoserine phosphatase. From the pathogenic point of view, the PP in the brain is particularly relevant, as genetic defects of any of the three enzymes are associated with a group of neurometabolic disorders known as serine deficiency disorders (SDDs). We recombinantly expressed and characterized eight variants of PSAT associated with SDDs and two non-SDD associated variants. We show that the pathogenetic mechanisms in SDDs are extremely diverse, including low affinity of the cofactor pyridoxal 5′-phosphate and thermal instability for S179L and G79W PSAT, loss of activity of the holo form for R342W PSAT, aggregation for D100A PSAT, increased Km for one of the substrates with invariant kcats for S43R PSAT, and a combination of increased Km and decreased kcat for C245R PSAT. Finally, we show that the flux through the in vitro reconstructed PP at physiological concentrations of substrates and enzymes is extremely sensitive to alterations of the functional properties of PSAT variants, confirming PSAT dysfunctions as a cause of SSDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Parma, 43124 Parma, Italy.
- Department of Food and Drug, University of Parma, 43124 Parma, Italy.
- Biopharmanet-TEC, University of Parma, 43124 Parma, Italy.
- Department of Chemistry/Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.
- The Protein Factory 2.0, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
- Institute of Biophysics, CNR, 56124 Pisa, Italy.
ORCID-Profile: Annalisa Bianchera, Davide Cavazzini, Loredano Pollegioni, Giulia Murtas, Andrea Mozzarelli, Stefano Bettati, Alessio Peracchi, Barbara Campanini
Förderung
- PRIN-2017—Dissecting Serine Metabolism in the Brain
Zitieren
APA
Marchesani, F., Michielon, A., Viale, E., Bianchera, A., Cavazzini, D., Pollegioni, L., Murtas, G., Mozzarelli, A., Bettati, S., Peracchi, A., Campanini, B., & Bruno, S. (2023). Phosphoserine Aminotransferase Pathogenetic Variants in Serine Deficiency Disorders: A Functional Characterization. Biomolecules. https://doi.org/10.3390/biom13081219
Vancouver
Marchesani F, Michielon A, Viale E, Bianchera A, Cavazzini D, Pollegioni L, et al. Phosphoserine Aminotransferase Pathogenetic Variants in Serine Deficiency Disorders: A Functional Characterization. Biomolecules. 2023. doi:10.3390/biom13081219
BibTeX
@article{Marchesani2023,
author = {Marchesani, Francesco and Michielon, Annalisa and Viale, Elisabetta and Bianchera, Annalisa and Cavazzini, Davide and Pollegioni, Loredano and Murtas, Giulia and Mozzarelli, Andrea and Bettati, Stefano and Peracchi, Alessio and Campanini, Barbara and Bruno, Stefano},
title = {Phosphoserine Aminotransferase Pathogenetic Variants in Serine Deficiency Disorders: A Functional Characterization},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13081219}
}
EUVIMED